Brostallicin
![]() | |
| Names | |
|---|---|
| IUPAC name
4-[(2-Bromoacryloyl)amino]-N-{5-[(5-{[5-({2-[(diaminomethylene)amino]ethyl}carbamoyl)-1-methyl-1H-pyrrol-3-yl]carbamoyl}-1-methyl-1H-pyrrol-3-yl)carbamoyl]-1-methyl-1H-pyrrol-3-yl}-1-methyl-1H-pyrrole-2-carboxamide | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
| Properties | |
Chemical formula |
C30H35BrN12O5 |
| Molar mass | 723.593 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Brostallicin is a chemical compound being studied in the treatment of cancer. It is an alkylating agent that binds DNA.[1]
References
- ↑ Brostallicin entry in the NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document: "Dictionary of Cancer Terms".
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
